Recent GWAS studies, demonstrating the role of specific genetic variance affecting APP and Aβ processing, showed, at the same time, a tight correlation between immune gene expression and the progression of AD, confirming the crucial role of neuroimmune interactions (Kunkle et al., 2019). This evidence concerns the gene APP and Alzheimer disease.